简体中文

Professionals

LIU,NickPartner

Tel:
+86 10 8567 2953
Fax:
+86 10 8567 5999
Email:
liuqinghui@anjielaw.com
Expertise:
Intellectual Property, Antitrust & Competition, Litigation & Arbitration
Information
    Qualification
    Attorney at law (China)

    Work Experience
    Beijing Anjie Law firm, Partner, Attorney at law
    Beijing High People’s Court, Senior Judge 
    The General Hospital of the PLA,  Legal Counsel


    Educations
    Beijing Normal University, Ph.D. in Civil and Commercial Law
    Peking University, L.L.M in Economic Law
    Nanjing Political College of PLA, M. Mgt
    The PLA Air Force Institute of Politics, B.A. 

     
    Honors & Recognition
    The World’ s Leading Patent Professionals-IAM Patent 1000 (2020)
    Recommended Intellectual Property Lawyer in China-Legal 500 (2020)
    Intellectual property specialist in China jurisdiction-Global Law Expert(2020)
    Expert member of the amendment panel for the 14th edition of the ICC Intellectual Property Roadmap.


Work Highlights
Dr. Liu is a highly experienced and respected lawyer who concentrates his practice on the full spectrum of intellectual property, antitrust and competition, litigation and arbitration.

Before joining Anjie Law Firm, Dr. Liu had served as an prestigious intellectual property judge in Beijing High People’s Court for 10 years. He had adjudicated over 2,000 IP related cases, including civil cases and administrative cases, many of which had profound impacts on the IP industry practice. Dr. Liu especially specializes in cases regarding SEPs (standard essential patents), pharmaceutical patents and trademarks since he had well-rounded and extensive experience in such litigations during his time on the bench.

After joining AnJie Law Firm, Dr. Liu has handled numerous high-profile patent and other IP litigation cases, such as Qualcomm v. Apple and AstraZeneca v. Patent Re-examination Board. His IP team represented AstraZeneca in the patent administrative litigation, and successfully persuaded the court of second instance reversed the first-instance decision. It was a milestone case for chemical compound-related inventions and was rated as one of the “50 typical intellectual property cases in Chinese courts in the year of 2018”.

Dr. Liu published three IP related academic monographs, Guideline for Patent Infringement Litigation in China, Application of the Law on Invention/Utility Model Administrative Lawsuits – Rules and Cases and Liability of Internet Service Providers on Indirect Intellectual Property Infringement. These books received wide acclaim among lawyers in China and were regarded as guidelines for resolving various IP-related issues. Also, Dr. Liu published many influential IP-related articles and essays in some well-known journals and magazines.

Dr. Liu is often invited as a guest of honor by many major Intellectual Property conferences and convention, where he delivered some keynote speeches such as patent administrative litigation practices and issues, the rules for determining patent infringement and interpreting patent claims, the rules for determining trademark infringement, etc.


Representative Matters
(1)Patent Related Representative Matters
  • Represented Rechsand Science & Technology Group in an invention patent infringement case before the Supreme Court of China and led his IP team successfully persuaded the Justices to reverse the first instance court decision.
  • Represented AstraZeneca for administrative litigation, a series of cases concerning invalidation of invention patent“Ticagrelor”“Ticagrelor polymorph” and “Ticagrelor intermediates and preparation methods”; in the “Ticagrelor” case, he led his IP successfully persuaded the court of second instance to reverse the first-instance decision (AstraZeneca v. Patent Re-examination Board case). This is a milestone case in recent years for chemical compound related inventions, and was rated as one of the 50 Typical Intellectual Property Cases In The Year Of 2018.
  • Representing AstraZeneca for patent infringement litigations against several generic drug companies.
  • Represented Qualcomm for major invention patent litigations against Apple.
  • Representing Cambrios against C3nano in a series of cases concerning invalidation of key invention patents.
  • Representing Novo Nordisk for administrative litigation, a case concerning invalidation of invention patent “lilalutide preparation”.
  • Participated in the trial of Iwncomm Wireless Network Communication Co. Ltd. v. Sony Mobile Communications Co. Ltd. - a case about WAPI standard essential patent (SEP).
  • Participated in the trial of Novartis case about invalidation of a patent entitled “Pharmaceutical Composition for Treating Gastrointestinal Matrix Tumors”.
  • Participated in the trial of E. I. du Pont de Nemours and Company case about rejection of an invention patent entitled “Azeotropic Composition and Its Application”.
  • Participated in the trial of Mitsubishi Tanabe Pharma Corporation v. Pant Reexamination Board of CNIPA case.
  • Participated in the trial of Boehringer Ingelheim GmbH v. Patent Reexamination Board of CNIPA case concerning invalidation of a patent entitled “Medicine for the Treatment of Chronic Obstructive Pulmonary Disease”.
  • Participated in the trial of Celgene Technology Company’s appealing case relate to invention patent application refusal of invention patent titled “Quinazolone Derivative”.
  • Participated in the trial of Funate Corporation in a reexamination case of rejection of “Method for preparing carbon nanotube structure” invention patent.
  • Participated in the trial of ABBVIE v. Patent Reexamination Board of CNIPA, appeal case relate to rejection of patent application of “solid pharmaceutical dosage form”.
  • Participated in the trial of Harbin Pharmaceutical Group in invalidation of invention patent case. 
  • Participated in the trial of Apple Inc. v. Shanghai Zhizhen Network Technology ("Little I Robot" administrative suit).

(2)Trademark Related Representative Matters
  • Representing Tecent for several trademark litigations.
  • Participated in the trial of Infringement of trademark case concerning whether parallel importation of trademark constitutes infringement.
  • Participated in the trial of Infringement of trademark and unfair competition case concerning whether non-standard use of registered trademark constitutes infringement.
  • Participated in the trial of Administrative dispute case of “qingyang” trademark, creatively held that Article 41 of Trademark Law (2001) (Article 44 of 2013 Trademark Law) can be referentially applicable in trademark application review, authorization and related litigation process. This case was selected as “Ten” most important intellectual property cases of Beijing Court and was selected as No.24 reference case in Beijing Courts by Higher People’s Court of Beijing.
  • Participated in the trial of Reexamination dispute case of the objection of trademark of “Perrier-Jouet”, this case was selected as No. 10 reference case in Beijing Courts by Higher People’s Court of Beijing.
  • Participated in the trial of Objection of trademarks case of DreamWorks Animation SKG, Inc. about “Kungfu Panda” and “How to Train Your Dragon”, concerning the protection of prior interest in the process of registration of trademarks.
  • Participated in the trial of Invalidation of trademark case of DMACK concerning the determination of trademark squatting of representatives and agents.
  • Participated in the trial of Trademark objection case about “shuangshou”, concerning whether overseas use and passive use constitutes prior interest of unregistered trademarks.
  • Participated in the trial of Rejection of trademark application of “VINCE”, concerning the effect of trademark coexistence agreement in the determination of trademark approximation.
  • Participated in the trial of Rejection of “Guojing” trademark case, concerning whether trademark including character “country” has adverse effects.

(3)Unfair Competition Related Representative Matters
  • Participated in the trial of Unfair competition case concerning whether unauthorized use of trade names in other people’s corporation names constitutes unfair competition.

(4) Copyright Related Representative Matters
  • Participated in the trial of Copyright dispute case concerning whether aircraft shape and model constitutes work 

Selected Publications
  • · Guideline for Patent Infringement Litigation in China (China Legal Publishing House, April 2019)
  • · Application of the Law on Invention/Utility Model Administrative Lawsuits – Rules and Cases (Intellectual Property Publishing House, September 2017)
  • · Liability of Internet Service Providers on Indirect Intellectual Property Infringement (Intellectual Property Publishing House, September 2018)
  • · Determination of Similar Trademarks and Similar Goods: Standards, Problems and Solutions, Intellectual Property Journal, ISSUE 4 (2003), Chinese Social Sciences Citation Index (CSSCI)
  • · Patent Claim Construction in Patent Appeal Proceedings, Intellectual Property Journal, ISSUE 6, (2017), CSSCI
  • · Application of the Good Faith Principle in Trademark Appeal and Cancellation Proceedings, Social Sciences of Beijing, ISSUE 11 (2015), CSSCI
  • · Review of Liabilities of Illegal Use of Patented Products, Yunnan Normal University Journal, ISSUE 6 (2015), CSSCI
  • · The “Broadest Reasonable Interpretation” of Patent Claim: United States Experiences and Its Reference Significance, China Patents & Trademarks, ISSUE 1 (2017)
  • · Application of Law on Inappropriate Trademark Application Behavior during Trademark Registration Process, The People’s Judicature, ISSUE 24 (2015)
  • · Determination Standard of Trademark Rights – Take “Sony Ericsson” and “Viagra” Trademark Disputes as Example, Retrospect and Prospect of Trademark Trial – in Memory of 30 Years since the Issue of Trademark Law (the People’s Court Publishing House, December 2013)
  • · Review of China’s Well-known Trademark System – Starting from Application of Article 13 of the Trademark Law, Electronics Intellectual Property, ISSUE 4 (2014)
  • · The Nature, Problems and Reconstruction of China’s Patent Reexamination System, Electronics Intellectual Property, ISSUE 11 (2015)
  • · Patent Claim Construction under Contextualism, Electronics Intellectual Property, ISSUE 7 (2016)
  • · Determination of the Scope of Reexamination for Trademark Opposition – Concurrently Discuss Understanding and Application of Article 28 of the Trademark Review and Adjudication Rules, China Trademark, ISSUE 11 (2013)
  • · Analysis on the Working Guidelines Concerning Trial of Standard and Essential Patent Disputes by Guangdong Higher People’s Court (For Pilot Implementation), Zhichanli,2019
Beijing Office

19/F, Tower D1, Liangmaqiao Diplomatic Office Building, No. 19 Dongfangdonglu, Chaoyang District, Beijing 100600

Tel:+86 10 8567 5988

Fax:+86 10 8567 5999

Shanghai Office

28/F, K.Wah Center,
No. 1010 Huaihai Road (M), Shanghai 200031

 

Tel:+86 21 2422 4888

Fax:+86 21 2422 4800

Shenzhen Office

38/F, Tower 3, Kerry Plaza,
No. 1-1 Zhongxinsi Road, Futian District, Shenzhen 518041

Tel:+86 755 8285 0609

Fax:+86 755 8285 0605

Follow us:

WeChat sweep
© 2016 - Copyright ANJIE - All Rights Reserved Designed by GreatMo